🔎 Trials Near Me

Akèy › Obèsite › Ohio › Cincinnati

Etid klinik pou Obèsite nan Cincinnati, OH

19 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Cincinnati (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • CTI Clinical Research Center /ID# 282043, Cincinnati
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Ap rekriteFaz 3
  • Midwest Eye Center, Cincinnati
  • Velocity Clinical Research, Mt. Auburn, Cincinnati
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • CTI Clinical Research Center, Cincinnati
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Ap rekriteFaz 3
  • CTI Clinical Research Center, Cincinnati
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Velocity Clinical Research - Auburn, Cincinnati
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • CTI Clinical Research Center, Cincinnati
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, Cincinnati
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Cincinnati
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • CTI Clinical Research Center, Cincinnati
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Clinical Trial Investigator Clinical Research Center, Cincinnati
  • Velocity Clinical Research - Cincinnati, Cincinnati
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • Velocity Clinical Research - Cincinnati, Cincinnati
  • Velocity Clinical Research - Springdale, Cincinnati
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Lindner Center,Christ Hospital, Cincinnati
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

Ap rekriteFaz 1Volontè an sante akeyi
  • Medpace Clinical Pharmacology Unit, Cincinnati
Laj 18 a 65 · Tout sèks · Mizajou May 4, 2026 · NCT07219589

Effects of Exercise on Lipids and Endothelial Function in Youth

Ap rekrite
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Laj 10 a 20 · Tout sèks · Mizajou Feb 13, 2026 · NCT07409064

A Novel Obesity Prevention Program for High-Risk Infants in Primary Care

Ap rekriteFaz 2Volontè an sante akeyi
  • Hopple Street Neighborhood Health Center, Cincinnati
1 Day · Tout sèks · Mizajou Mar 5, 2025 · NCT06028113

Etid Obèsite nan lòt vil

Lòt etid nan Cincinnati

Sous ClinicalTrials.gov, done yo ranmase Oct 4, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.